This compound is primarily utilized in pharmaceutical research as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a bromo and methyl-substituted aromatic ring, makes it valuable in the development of drugs targeting neurological and psychiatric disorders. It is often employed in the preparation of compounds that interact with neurotransmitter receptors, particularly those involved in dopamine and serotonin pathways. Additionally, its chiral nature allows for the creation of enantiomerically pure drugs, enhancing specificity and reducing side effects. This chemical is also explored in the design of potential therapeutic agents for inflammatory and autoimmune diseases due to its ability to modulate specific biological pathways.